Logo image
Back
Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation : What is the optimal timing?
Journal article   Open access   Peer reviewed

Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation : What is the optimal timing?

Rasih Atilla Ener, Sharon B Meglathery, Bulent Cuhaci, David Topolsky, Michael J Styler, Pamela Crilley, Isadore Brodsky, S. Benham Kahn and Reginald S King
American journal of clinical oncology, v 24(1), pp 19-25
2001
DOI: https://doi.org/10.1097/00000421-200102000-00003
PMID: 11232944
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1097/00000421-200102000-00003View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze),  Open

Abstract

Antineoplastic agents Biological and medical sciences Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Medical sciences Pharmacology. Drug treatments

Metrics

5 Record Views
7 citations in Web of Science
8 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Oncology
Logo image